The Global Cardiac Marker Market is estimated to be USD 3.2 Bn in 2021 and is expected to reach USD 4.95 Bn by 2026, growing at a CAGR of 9.1%.
However, Technical issues related to the sample collection and storage and the high cost involved in cardiac marker testing are expected to hamper the market growth.
By Type, the market is classified into Myocardial Muscle Creatine Kinase (CK-MB), Troponins (T and I), Myoglobin, Natriuretic Peptides (BNP, NT-proBNP), High-sensitivity C-reactive Protein (hs-CRP), and Others. Amongst all, the Troponins (T and I) segment is estimated to hold the highest market share during the forecast period.
By Components, the market is classified as Reagents & Kits and Instruments. Amongst the two, the Instruments segment is estimated to hold the highest market share during the forecast period.
By Location of Testing, the market is classified as Laboratory Testing and Point of Care Testing. Amongst all, the Laboratory Testing segment is estimated to hold the highest market share during the forecast period.
By Application, the market is classified into Myocardial Infarction, Congestive Heart Failure, Acute Coronary Syndrome, Atherosclerosis, and Others. Amongst all, the Myocardial Infarction segment is estimated to hold the highest market share during the forecast period.
By Geography, North America is projected to lead the market.
Market Dynamics
The factors such as the rise in prevalence of cardiac diseases, unique features of a cardiac biomarker such as high accuracy, quick outcomes, and economical pricing of cardiac point of care (POC) testing are driving the market. Additionally, the growing awareness among patients and healthcare providers about the importance of early diagnosis and care of various CVDs is driving the demand for cardiac markers. The rise in investment in research and the development of advanced technologies in the field of novel cardiac biomarkers and personalized medicine is expected to create lucrative opportunities for the growth of the market.However, Technical issues related to the sample collection and storage and the high cost involved in cardiac marker testing are expected to hamper the market growth.
Market Segmentation
The Global Cardiac Marker Market is segmented further based on Type, Components, Location of Testing, Application, and Geography.By Type, the market is classified into Myocardial Muscle Creatine Kinase (CK-MB), Troponins (T and I), Myoglobin, Natriuretic Peptides (BNP, NT-proBNP), High-sensitivity C-reactive Protein (hs-CRP), and Others. Amongst all, the Troponins (T and I) segment is estimated to hold the highest market share during the forecast period.
By Components, the market is classified as Reagents & Kits and Instruments. Amongst the two, the Instruments segment is estimated to hold the highest market share during the forecast period.
By Location of Testing, the market is classified as Laboratory Testing and Point of Care Testing. Amongst all, the Laboratory Testing segment is estimated to hold the highest market share during the forecast period.
By Application, the market is classified into Myocardial Infarction, Congestive Heart Failure, Acute Coronary Syndrome, Atherosclerosis, and Others. Amongst all, the Myocardial Infarction segment is estimated to hold the highest market share during the forecast period.
By Geography, North America is projected to lead the market.
Recent Developments
1. Roche announces five new intended uses for key cardiac biomarkers to help identify cardiovascular risk, better diagnose patients and support early treatment. - 28th April 2021Company Profiles
Some of the companies covered in this report are Abbott Laboratories, Beckman Coulter, Inc. bioMérieux SA, Johnson and Johnson, Olympus Corporation, etc.Competitive Quadrant
The report includes Competitive Quadrant, a proprietary tool to analyze and evaluate the position of companies based on their Industry Position score and Market Performance score. The tool uses various factors for categorizing the players into four categories. Some of these factors considered for analysis are financial performance over the last 3 years, growth strategies, innovation score, new product launches, investments, growth in market share, etc.Why buy this report?
- The report offers a comprehensive evaluation of the Global Cardiac Marker Market. The report includes in-depth qualitative analysis, verifiable data from authentic sources, and projections about market size. The projections are calculated using proven research methodologies.
- The report has been compiled through extensive primary and secondary research. The primary research is done through interviews, surveys, and observation of renowned personnel in the industry.
- The report includes an in-depth market analysis using Porter’s 5 forces model and the Ansoff Matrix. In addition, the impact of Covid-19 on the market is also featured in the report.
- The report also includes the regulatory scenario in the industry, which will help you make a well-informed decision. The report discusses major regulatory bodies and major rules and regulations imposed on this sector across various geographies.
- The report also contains the competitive analysis using Positioning Quadrants, the analyst’s Proprietary competitive positioning tool.
Report Highlights:
- A complete analysis of the market, including parent industry
- Important market dynamics and trends
- Market segmentation
- Historical, current, and projected size of the market based on value and volume
- Market shares and strategies of key players
- Recommendations to companies for strengthening their foothold in the market
Frequently Asked Questions about the Global Cardiac Marker Market
What is the estimated value of the Global Cardiac Marker Market?
What is the growth rate of the Global Cardiac Marker Market?
What is the forecasted size of the Global Cardiac Marker Market?
Who are the key companies in the Global Cardiac Marker Market?
Report Attribute | Details |
---|---|
No. of Pages | 185 |
Published | June 2021 |
Forecast Period | 2021 - 2026 |
Estimated Market Value ( USD
| USD 3200 Million |
Forecasted Market Value ( USD
| USD 4950 Million |
Compound Annual Growth Rate | 9.1% |
Regions Covered | Global |
No. of Companies Mentioned | 25 |
Table of Contents
1 Report Description
2 Research Methodology
3 Executive Summary
4 Market Influencers
5 Market Analysis
6 Global Cardiac Marker Market, By Type
7 Global Cardiac Marker Market, By Components
8 Global Cardiac Marker Market, By Location of Testing
9 Global Cardiac Marker Market, By Application
10 Global Cardiac Marker Market, By Geography
11 Competitive Landscape
12 Company Profiles
13 Appendix
Companies Mentioned
- Abbott Laboratories
- Advanced ImmunoChemical
- AgPlus Diagnostics Ltd
- Alere Inc
- Beckman Coulter, Inc.
- Becton Dickinson and Company
- BG Medicine
- BioLegend
- BioMerieux, Inc.
- Bio-Rad Laboratories, Inc.
- Boditech Med Inc
- Danaher Corporation
- F. Hoffmann-La Roche Ltd.
- Guangzhou Wondfo Biotech Co., Ltd
- Johnson and Johnson
- LSI Medience Corporation
- Ortho Clinical Diagnostics
- Olympus Corporation
- PerkinElmer Inc.
- Randox Laboratories Ltd.
- Roche Diagnostics Corporation
- Siemens Healthcare
- Siemens AG
- Thermo Fisher Scientific
- Tosoh Corporation